biotech stock review, zestra

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!

Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...
Regoxidine, biotech stock review

Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.

Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.

3M to Acquire Wound Care Technology Co., Acelity for $6.7 Billion.

Chronic wounds represent a large and growing threat to public health. In the US alone, they affect over 6.5 million people. As...

Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.

‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg). (Bloomberg) -- Shares of the tiny biotechnology company...

Adding Vaccinex (VCNX) $5.50, to Watch List After Investor Presentation.

IPO Tumbles in Aftermarket, from $12 underwritten by Oppenheimer, BTIG and Ladenburg Thalmann, to a low of $3 in six months.
biotech stock review

Mustang Bio (MBIO)$4.12, Reports 2018 Results.

Mustang Bio Reports Full-Year 2018 Financial Results And Recent Corporate Highlights GlobeNewswire - Mon Mar 18, 6:29AM CDT
biotech stock review, dyadic

Must Watch Video: Dyadic’s (DYAI) Matthew Jones.

Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho...

Two Biotech Stocks on Takeover List?

Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD). Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand...

Latest article

Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.

Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter...

MySize (MYSZ) in Jerusalem Post.

Israeli Start-Up MySize Eases Retail's Online Returns Problems. While the company launched its SizeUp application in late 2015,...

Short Squeeze Alert.

Internet Stock Review Adds Ebix (EBIX) $39 to Watch List. Short Squeeze Coming? Price Target $110.